Baseline Descriptive | ReRA (n=69) | non-ReRA (n=282) | Sig. |
---|---|---|---|
% Female | 94.2 | 73.4 | <0.001 |
% RF + | 56.5 | 62.1 | 0.398 |
% ACPA + | 60.9 | 61.0 | 0.985 |
Time to Treatment* | 3.17 (4.10) | 1.34 (2.70) | 0.001 |
SDAI | 25.54 (12.24) | 17.70 (12.17) | <0.001 |
CRP† | 2.02 (2.30) | 1.80 (2.02) | 0.435 |
SJC 28 | 6.42 (5.35) | 4.64 (4.72) | 0.009 |
TJC 28 | 9.22 (6.98) | 4.35 (5.40) | <0.001 |
EGA‡ | 37.78 (20.49) | 28.77 (21.40) | 0.002 |
PGA‡ | 55.19 (26.67) | 41.42 (26.67) | <0.001 |
*years; †mg/dl; ‡100mm VAS scale.